Aphria OverviewTrack Aphria's EBIT ($-74M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Feb 28, 2021
Trailing 12 months ending Feb 28, 2021
As of the most recent data (February 2021), APHA shows a EBIT of $-74M. That is below the Healthcare sector average of $99B. Scroll down for historical charts and peer comparison views.
The Healthcare sector average EBIT is about $99B. Aphria is at $-74M, which is lower that average. That is roughly 100.1% below the sector mean. Use the comparison chart on this page to see how APHA stacks up against individual peers as well.
Tracking APHA's ebit over time shows whether Aphria is scaling, shrinking, or reshaping that part of the business. The current reading is $-74M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Aphria's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-74M) with ownership activity and broader fundamentals.
The Healthcare average EBIT is about $99B, while APHA is at $-74M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
